RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
HTA Oncology Recommendations Have Grown More Restrictive Over Time
Of the 329 oncology HTAs analyzed from the period 2013–2017, 29% resulted in positive recommendations without restrictions.
Avalere Releases Patient-Perspective Value Framework Scoring Methodology Report
Today, Avalere published a technical appendix to the PPVF Version 1.0 methodology report, outlining a quantitative method for incorporating patient preferences into value assessments and healthcare decision making.
Podcast: E2 – Real-World Evidence: Is It a Game Changer for the FDA?
Tune in to episode 2 of our discussion covering why the FDA is so interested in real-world evidence and how they are approaching it.
Avalere Expands Actuarial and Data Analytics Expertise with Hire of Kenny Kan
Kenny Kan has joined the Avalere team leading the firm's actuarial analytics. Prior to joining Avalere, Kan served as the Chief Actuary at Humana and CareFirst.
Gillian Woollett’s Research Published in BioDrugs
Gillian Wollett, Senior Vice President of Avalere’s FDA & Regulatory Policy team, recently published “A ‘Global Reference’ Comparator for Biosimilar Development” in BioDrugs.
Issue Brief: The Promise of Shared Decision-Making in Improving Value in the US Healthcare System
Evidence suggests that shared decision-making can play a role in advancing a value-based care delivery system.
Christie Teigland Contributes to NQF’s Disparities Report
Avalere’s Teigland was selected by the National Quality Forum to participate in the Disparities Standing Committee.
Podcast: Key Differences Within the Patient-Perspective Value Framework
Tune in as our experts discuss the key differences making the the Patient-Perspective Value Framework 1.0 (PPVF) unique compared to value frameworks currently in the market.
Avalere to Participate in National Academies of Medicine Panel
On Tuesday, June 13, Christie Teigland, PhD, will participate in a panel discussion entitled “Measuring and Reporting Social Risk Factors” as part of a dissemination meeting on the report series “Accounting for Social Risk Factors in Medicare Payment,” sponsored by the National Academies of Medicine.
Webinar: Outcomes-Based Contracting: Master the Challenges
Avalere experts examine the challenges and successful approaches to outcomes-based contracts.
Health Plans Are Actively Exploring Outcomes-Based Contracts
Avalere experts say use of outcomes-based contracts could further goals to improve patient outcomes and manage drug costs
Avalere and FasterCures Co-Author Blog Post Featured in Health Affairs
Blog post features key learnings from the Patient-Perspective Value Framework.
Avalere and FasterCures Release Patient-Perspective Value Framework to Incorporate Patient Preferences into Healthcare Treatment Decisions
Today, Avalere and FasterCures published Version 1.0 of the Patient-Perspective Value Framework (PPVF).
Avalere Panel Highlights the Importance of Analytics in Value-Based Care
At the Asembia Specialty Pharmacy Summit 2017, an Avalere-led panel identified three focus areas for specialty pharmacies looking to achieve market leadership in an increasingly value-based care environment.
Payer Insights on the Use of Patient Data
Avalere recently partnered with the National Pharmaceutical Council to examine payers' perspectives regarding the use of patient data and how it can be used to shape care delivery, improve system efficiencies, and achieve better health outcomes.
FasterCures Commits Seed Funding for Phase 2 of Patient-Perspective Value Framework (PPVF) Initiative
This week, FasterCures provided Avalere with a second round of seed funding to test, refine, and validate the PPVF.
Initial Analysis of ICER’s Value Framework Update
Today, the Institute for Clinical and Economic Review (ICER) released an updated version of its Value Assessment Framework.
Avalere to Support Boehringer Ingelheim in Outcomes-Based Contracting
Avalere will empower expanded insight and improvement in outcomes for value-based diabetes medications, using Inovalon’s data resources and advanced value-based care platforms.
Promoting Shared Decision Making Around Costs to Improve Value
Avalere and the Robert Wood Johnson Foundation Launch Eight Grants to Improve Cost-of-Care Conversations Between Patients and Clinicians.
Overview of Appropriate Use Criteria for Treating Knee Osteoarthritis
Earlier this year, Avalere led a work group of rheumatology, orthopedic surgery, psychiatry, sports medicine, and primary care clinicians to develop appropriate use criteria for the use of hyaluronic acid (HA) in the treatment of knee osteoarthritis (OA).